You might have to experience the end of the world sober, after all.
Thats because climate change will unleash havoc on the world of drugs. And it may be a whole lot tougher on the most mainstream stimulantsgrocery store stuff like coffee, beer and winethan on hardcore illicit narcotics like heroin, cocaine and meth.
Some of those more-powerful, more-addictive, mind-altering substances appear relatively better prepared to survive the oncoming climate crisis than the vulnerable plants responsible for producing traditionally legal recreational highs, according to a review of recent scientific studies and interviews with experts on climate and agriculture by VICE News.
Heroin, for example, is already getting a boost from climate change. One study shows that rising levels of atmospheric carbon dioxide have doubled the potency of poppies, the plant used to make the drug. Wine, by contrast, is under serious threat, as changing weather patterns and raging wildfires put celebrated vineyards in jeopardy.
All plant-based drugs, whether theyre narcotics or used for medicine, are going to change, Lewis Ziska, lead author of the poppy study and now an associate professor of environmental health sciences at Columbia Universitys Mailman School of Public Health, told VICE News. In fact, the world is changing faster than our ability to describe the changes.
Though big questions remain about how climate change will impact agriculture, and experts caution that much research remains to be done, long-term agricultural consequences are just starting to come into view.
The short version: The drug world is facing a big shake-up.
To make this easier, we put the results into an oversimplified but handy-dandy chart.
For a more detailed picture, read on.
BEER: DOUBLE THE PRICE
Get ready to pay more for brew.
Climate change might make beer twice as expensive, according to a 2018 study. In Ireland, one of the heaviest beer-drinking countries in the world, the price could triple.
Thats because the cost of a key ingredient, malted barley, could soar as global average temperatures rise and barley becomes harder to grow.
The price of a six-pack in the United States might rise by as much as $8 on average, the study found.
Pricey beer is just another way climate change will suck, tweeted Steven J. Davis, one of the authors of the study.
WINE: A HINT OF ASHTRAY
Wine is decidedly in trouble.
At least, the good stuff is: Those who savor the fine distinctions between a pinot noir and a cabernet sauvignon, or a Bordeaux and a Chateauneuf-du-pape, are going to hate the future.
The world may still be able to produce the same amount of wine as before. But the quality, taste and variety of wines will change, said Benjamin Cook, a NASA climate scientist who has studied the impact of climate change on wine-growing regions.
You can grow wine grapes almost anywhere and make wine with them. Thats why you can go to Trader Joes and get 4-buck chuck, Cook told VICE News. Wine that has these characteristics that make it famous and expensive and high value, thats where the impacts are going to potentially be very severe.
Those nuances depend on the regional mix of weather, rainfall, temperature and humidityall of which will be thrown into chaos. Warmer wine-growing regions, like Australia and California, will be particularly hard hit, Cook said.
California vineyards are especially threatened by the recent surge of climate change-linked wildfires. Grapes that escape the flames can absorb chemicals from smoke that ruin their taste, leaving the dreaded smoke taint. Some winemakers complain that smoke exposure is giving their wine an ashy finish, according to The Washington Post.
Others are reaching for solutions. Kwaw Amos, owner of New Yorks Gotham Winery, blends traditional European grapes with hardier American varieties to create hybrids with better protection against heat, fungus and early budding.
The concept of hybrids is nothing new in grape growing, Amos told VICE News. Cabernet sauvignon is a hybrid. Its just now youre thinking about the next level hybrids that were going to need given whats happening.
COFFEE: DARK TIMES
Coffee is in danger.
About half of all land now used to grow the two main species of coffee, arabica and robusta, may no longer be usable by 2050, according to one estimate. Arabica and robusta make up 99 percent of the commercial supply globally, and have a limited ability to relocate to different climates.
Another study found that six-in-ten of the known species of coffee are now under threat of extinction. Experts believe higher temperatures encourage pesky fungus growth on coffee beans. Changes in rainfall patterns may also put an added stress on the plants.
Good coffee will probably become increasingly harder to grow. And that could become a global economic issue, considering the industry employs over 125 million people, including farmers, distributors and brewers. And, like beer, coffee could also get more expensive.
U.S. consumers should expect much more expensive and lower-quality coffee because of rising temperatures, extreme rainfalls, and higher frequency of severe droughts, Titus O. Awokuse, who chairs the department of agricultural, food and resource economics at Michigan State University, recently told the LA Times.
COCAINE: FINE, THANKS
Coca, the plant responsible for cocaine, is notoriously difficult to get rid of. And that likely means it will survive pretty well compared to more-vulnerable plants.
Charles Helling, a scientist who studied the crop as a soil chemist with the U.S. Department of Agriculture, has said he thinks higher temperatures wont be harmful, and that they may just encourage the plant to grow at even higher elevations.
"Coca is kind of unique, because it's got a very heavy wax cuticle, a layer on the leaves," Helling told Scientific American. "So that tends to protect it from water loss. It's a pretty hardy shrub. It's actually a lot hardier than a typical crop plant."
Another factor in cocas favor may be genetic diversity. Plants that have been extensively cultivated in mainstream agriculture tend to become more genetically homogeneous, Ziska said. Whereas plants that have thrived in the wildnot to mention, survived sustained attempts at eradicationmay demonstrate greater genetic variability that helps them respond more flexibly to a changing environment.
Its still unclear whether coca would benefit from such an advantage.
HEROIN: AS YOU LIKE IT
Poppy plants, as noted above, have already become twice as potent in natural morphine as they were in the middle of last century, thanks to rising levels of atmospheric carbon dioxide, or C02, the gas thats principally responsible for climate change, according to one study.
That study was performed in 2008, and atmospheric C02 has only continued to rise since. Pumping even more of that gas into the air may triple morphine levels by 2050, and increase potency by a factor of 4.5 by the year 2090, according to the same study.
Ziska said the reason isnt yet completely certain. But he said one theory suggests that when a given resource becomes more prevalent in an environment, plants will tend to produce more secondary compounds that are rich in that resource, and that this dynamic explains why rising atmospheric CO2 prompts poppy plants to produce more morphine.
Poppy also has another advantage that makes the plant well-suited to a drier climate: Its particularly drought-resistant.
The poppy's hardiness has enabled growers in Afghanistan, a narcostate which provides 90% of the worlds opium, to notch record harvests over the last decade.
CANNABIS: ITS COMPLICATED
Weed will probably be okaymostly.
The plant is likely well-suited to survive a moderately hotter and drier climate, according to Olufemi Ajayi, the author of a recent study on the relative dangers posed by insect pests to cannabis in the context of climate change.
But, he cautioned, only within limits. More extreme temperatures and droughts will stunt growth, or kill plants, he said.
Another 2011 study on the impact of higher concentrations of carbon-dioxide found that the plant may be able to survive under expected harsh greenhouse effects including elevated CO2 concentration and drought conditions.
Cannabis does have an otherwise unsavory link to environmental degradation, however (as do a lot of drugs: see our previous reporting here).
Indoor growing operations have spread rapidly along with broadening legalization, and they take a lot of electricity.
One estimate states that growing one ounce of cannabis indoors can emit as much greenhouse gas as burning through a large cars entire tank of gasolineor 7 to 16 gallons.
Most U.S. cannabis is grown indoors. As the industry expands, its energy consumption is expected to rise, too. In Colorado, emissions from cannabis farms already exceed those from the states coal mining industry.
In other words, weeds relationship to global warming is complex. Even if cannabis is well-positioned to withstand a moderately warmer climate, its own energy use and outsized carbon footprint will need to be accounted for if the world ever gets serious about reducing emissions.
SYNTHETIC DRUGS: FINE
The world of synthetic, lab-based drugs will likely see hardly any impact from climate change, experts including Ziska said. This is because theyre made in a lab, not grown in a field.
This diverse galaxy of stimulantswhich includes MDMA, speed, meth, LSD, synthetic cannabinoids, mephedrone, fentanyl, carfentanyl, and many morewill be relatively unaffected because much of it is far less dependent on the growth of specific agricultural crops.
Synthetic opioids, especially, have been responsible for a tidal wave of recent overdose deaths. The U.S. Centers for Disease Control estimates that 36,000 people died from synthetic opioid overdose in the U.S. in 2019, including from fentanyl, a drug 80-to-100 times stronger than morphine.
So as you contemplate the end of the world, just remember that coffee and beer may be in ever-shorter supply and growing more expensive within a few decadesbut that the worlds supply of killer fentanyl may be just as robust as ever.
See the original post:
Which Drugs Will Survive Climate Change? We Investigated. - VICE
- IOM not webcast today. Why Not? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- National Academies skeptical at Best. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Some Confusion Exists [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Why DTC Genomics IS Medicine. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- First Mari, Now Linda. Who's next? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Is it true? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Re-Reviewing the National Academies [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- The problem with nonclinicians....... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Crazy Night of Emails to Government [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Adrienne Carlson's Personalized Medicine. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Tell Me, How do you feel now? Sherpa's RX [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- This Just In. 23andMe to go to GPs. I love my readers!! [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Sorry so long away [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- 2D6 Rears its ugly head..... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Ok, Fine, Back to Plavix [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Kaiser a protoype for Collins' Aim [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- A few months late to the party.... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Stated Another Way....... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Excuse Me? Harvard and Navigenics? WTF? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Follow up to Yesterday's WTF? Harvard, Navi? and Pfizer??? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Did you get your kit? Thanks Dr. Rob from MedCo [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Gluco...Wha? Parkinson's Disease and Glucocerebrosidase mutations. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Away and now back, What did I miss???? 23andme layoffs? Selling Genomes for cheap up next! [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Change IS Needed. I agree with William, sometimes. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Good Enough Science? Apparently so at 23andme [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Long QT Syndrome, location matters [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Congratulations Generation Health. Nice pick up! [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- An argument 23andSerge can't win...23andme but not medicine [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Stop. Breathe. Repeat. An analysis of the direction of DTC Genomics Field. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Hey DTC genomics, Stay Private, Stay Alive, Go Public and Die [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- You can't have it both way. Either scared your genome is sold off or not. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- 15 Days Away Gives Time for Perspective. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- What about the SACGHS registry? Another missed opportunity? [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- AJHG is in and my Favorite Muin is in it! But He Is NOT the Father! [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Navigenics for 23andMe prices? [Last Updated On: December 18th, 2009] [Originally Added On: December 18th, 2009]
- Lp(a) Maybe there's something there that wasn't there before? [Last Updated On: December 24th, 2009] [Originally Added On: December 24th, 2009]
- Another Year, Another Bankruptcy [Last Updated On: December 31st, 2009] [Originally Added On: December 31st, 2009]
- 5 Technologies going bye bye in this decade? [Last Updated On: January 6th, 2010] [Originally Added On: January 6th, 2010]
- Hackers, HITECH and HIPAA in DTC Genomics, Oh My! [Last Updated On: January 7th, 2010] [Originally Added On: January 7th, 2010]
- Personal Genomics Flop.....big Belly Flop! [Last Updated On: January 8th, 2010] [Originally Added On: January 8th, 2010]
- Gotta Love It. Even the daycare....... [Last Updated On: January 11th, 2010] [Originally Added On: January 11th, 2010]
- Congratulations Navigenics. You ARE a clinical lab! Uh-Oh... [Last Updated On: January 12th, 2010] [Originally Added On: January 12th, 2010]
- CETP, Jewish Centenarians and Alzheimers [Last Updated On: January 14th, 2010] [Originally Added On: January 14th, 2010]
- Enter the "Not" DTC Genomics Rep [Last Updated On: January 17th, 2010] [Originally Added On: January 17th, 2010]
- Why Dr. Vanier's Navigenics appointment is good for PM [Last Updated On: January 22nd, 2010] [Originally Added On: January 22nd, 2010]
- Holy Crap! MedCo Follows in CVS footsteps [Last Updated On: February 3rd, 2010] [Originally Added On: February 3rd, 2010]
- FDA, Warfarin, still not as sexy to me. [Last Updated On: February 5th, 2010] [Originally Added On: February 5th, 2010]
- Hype, Hype, Hype from a single study. [Last Updated On: February 11th, 2010] [Originally Added On: February 11th, 2010]
- I love my readers, even Renata M! [Last Updated On: February 17th, 2010] [Originally Added On: February 17th, 2010]
- How can insurers use DTC genomics to profile? [Last Updated On: February 17th, 2010] [Originally Added On: February 17th, 2010]
- 9p21.....ahem. Paynter et.al. Smackdown. Again. [Last Updated On: February 18th, 2010] [Originally Added On: February 18th, 2010]
- Hey! It's Pete Hulick! Are you Going to GET? [Last Updated On: February 19th, 2010] [Originally Added On: February 19th, 2010]
- I was wrong......AHEM [Last Updated On: February 28th, 2010] [Originally Added On: February 28th, 2010]
- G2C2, finally a tool for genomic education! [Last Updated On: March 2nd, 2010] [Originally Added On: March 2nd, 2010]
- Just 4 million? What 23andMe is worth. [Last Updated On: March 5th, 2010] [Originally Added On: March 5th, 2010]
- What a difference a year makes [Last Updated On: March 9th, 2010] [Originally Added On: March 9th, 2010]
- ........DTC Genomic Medicine? [Last Updated On: March 12th, 2010] [Originally Added On: March 12th, 2010]
- The FDA, 2c19 and the ACC [Last Updated On: March 13th, 2010] [Originally Added On: March 13th, 2010]
- The problem with Comparative Whole Genomics...... [Last Updated On: March 13th, 2010] [Originally Added On: March 13th, 2010]
- BRCA testing by 23andME is the same as Myriad Genetics. [Last Updated On: March 15th, 2010] [Originally Added On: March 15th, 2010]
- The Argument Against DTC Genomics Marketing and such [Last Updated On: March 16th, 2010] [Originally Added On: March 16th, 2010]
- A moment of Clarity. Some DTCG is not bad. [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- SNPs for breast cancer risk? It Depends. [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- How can MDVIP use Navigenics Test for Medicine? [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- Why did P&G invest in Navigenics? [Last Updated On: March 23rd, 2010] [Originally Added On: March 23rd, 2010]
- PGx in DTCG? Doesn't stand up to Useful testing. [Last Updated On: March 25th, 2010] [Originally Added On: March 25th, 2010]
- End of Gene Patents? [Last Updated On: March 29th, 2010] [Originally Added On: March 29th, 2010]
- Sherpa Accepting Chief Medical Officership [Last Updated On: April 3rd, 2010] [Originally Added On: April 3rd, 2010]
- The Rumors of My Death........ [Last Updated On: April 20th, 2010] [Originally Added On: April 20th, 2010]
- Happy DNA Day! [Last Updated On: April 25th, 2010] [Originally Added On: April 25th, 2010]
- 99 USD, DNA day and patient letters [Last Updated On: April 25th, 2010] [Originally Added On: April 25th, 2010]
- 2C19, Navigenics and Clinical Reality. [Last Updated On: May 1st, 2010] [Originally Added On: May 1st, 2010]
- Coriell Personalized Medicine Collaborative rising [Last Updated On: May 7th, 2010] [Originally Added On: May 7th, 2010]
- Personal Genomes in Clinical Care. Quake paper is a waste! [Last Updated On: May 11th, 2010] [Originally Added On: May 11th, 2010]
- Personal Genomes in Clinical Care. Quake paper Falls Short! [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- Last post edited by Drew [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- GateKeeper? FCUK U! [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- GateKeeper? F! U! [Last Updated On: May 15th, 2010] [Originally Added On: May 15th, 2010]
- Potential of genomic medicine, LOST [Last Updated On: May 19th, 2010] [Originally Added On: May 19th, 2010]
- How Bad Can a House Investigation be for DTC Genomics? [Last Updated On: May 20th, 2010] [Originally Added On: May 20th, 2010]